Background: Oral squamous cell carcinoma (OSCC) is a highly aggressive malignancy that is characterized by early distant metastasis and poor prognosis. DNA methylation plays an important role in the etiology and pathogenesis of OSCC. This study aimed to identify methylation-driven genes through bioinformatics analysis as potential biomarkers for early diagnosis and prognostic assessment of OSCC.
Methods: Methylation data, RNA sequencing (RNA-seq) data and clinical prognosis information of OSCC patients were retrieved from The Cancer Genome Atlas (TCGA) database. The R packages MethylMix were employed to analyze the correlation between methylation status and corresponding gene expression in tumor and normal tissues to obtain methylation-driven genes. Univariate Cox regression analysis was developed to further screen methylation-driven genes associated with the prognosis of OSCC patients. Subsequently, multivariate Cox regression analysis was utilized to construct a linear prognostic risk prediction model. Furthermore, a combined survival analysis integrating methylation and gene expression was performed to investigate the prognostic value.
Results: A total of 374 differentially expressed methylation-driven genes were identified. Seven methylation-driven genes (, , , , , , and ) were found to be significantly associated with patient prognosis. Additionally, four methylation-driven genes (, , and ) were used to construct a linear prognostic risk prediction model for OSCC patients. Furthermore, a combined Kaplan-Meier survival analysis revealed that three methylation-driven genes (, , ) alone can be used as independent prognostic markers or drug targets.
Conclusions: Our findings facilitate a better understanding of molecular mechanisms of OSCC and provide potential biomarkers of early diagnosis, precision treatment and prognosis evaluation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11231807 | PMC |
| http://dx.doi.org/10.21037/tcr-23-2303 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Identification of ALDH7A1 as a DNA-methylation-driven gene in lung squamous cell carcinoma.
Ann Med
December 2025
Department of Thoracic Surgery, The Affiliated LiHuiLi Hospital of Ningbo University, Ningbo, Zhejiang, China.
Background: Deoxyribose nucleic acid (DNA) methylation is an important epigenetic modification that plays an important role in the occurrence and development of tumors. Identifying key methylation-driven genes that affect the prognosis of lung squamous cell carcinoma (LUSC) can provide direction for targeted therapy research.
Methods And Results: Methylation and RNA-seq data were downloaded from The Cancer Genome Atlas (TCGA).
Development of a prognostic model for early-stage gastric cancer-related DNA methylation-driven genes and analysis of immune landscape.
Front Mol Biosci
October 2024
The School of Clinical Medical, Fujian Medical University, Fuzhou, Fujian, China.
Background And Aims: This study aimed to develop a prognostic model based on DNA methylation-driven genes for patients with early-stage gastric cancer and to examine immune infiltration and function across varying risk levels.
Methods: We analyzed data from stage I/II gastric cancer patients in The Cancer Genome Atlas which included clinical details, mRNA expression profiles, and level 3 DNA methylation array data. Using the empirical Bayes method of the limma package, we identified differentially expressed genes (DEGs), and the MethylMix package facilitated the identification of DNA methylation-driven genes (DMGs).
Effects of Differentially Methylated CpG Sites in Enhancer and Promoter Regions on the Chromatin Structures of Target LncRNAs in Breast Cancer.
Int J Mol Sci
October 2024
School of Physical Science and Technology, Inner Mongolia University, Hohhot 010021, China.
Aberrant DNA methylation plays a crucial role in breast cancer progression by regulating gene expression. However, the regulatory pattern of DNA methylation in long noncoding RNAs (lncRNAs) for breast cancer remains unclear. In this study, we integrated gene expression, DNA methylation, and clinical data from breast cancer patients included in The Cancer Genome Atlas (TCGA) database.
View Article and Find Full Text PDFDNA methylation-driven gene FAM3D promotes colorectal cancer growth via the ATF4-SESN2-mTORC1 pathway.
Aging (Albany NY)
October 2024
Department of Epidemiology, Public Health School of Harbin Medical University, Harbin, Heilongjiang, P.R. China.
Article Synopsis
- Colorectal cancer (CRC) has one of the highest mortality rates among cancers, and abnormal DNA methylation is a key factor in its progression.
- Researchers identified a 3-CpG methylation signature linked to CRC prognosis, focusing on the gene FAM3D, which has not been thoroughly studied before.
- Low expression and high methylation of FAM3D were found to be independent risk factors for CRC, as it promotes cancer cell growth and reduces sensitivity to common chemotherapy drugs by activating the mTORC1 pathway.
DNA methylation and gene expression profiling reveal potential association of retinol metabolism related genes with hepatocellular carcinoma development.
PeerJ
August 2024
Department of Transfusion, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Background: Aberrant DNA methylation patterns play a critical role in the development of hepatocellular carcinoma (HCC). However, the molecular mechanisms associated with these aberrantly methylated genes remain unclear. This study aimed to comprehensively investigate the methylation-driven gene expression alterations in HCC using a multi-omics dataset.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!